These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 33264481)
1. Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible? Yuan Z; Wang X; Geng X; Li Y; Mu J; Tan F; Xue Q; Gao S; He J Cancer Commun (Lond); 2021 Jan; 41(1):3-15. PubMed ID: 33264481 [TBL] [Abstract][Full Text] [Related]
2. Combining Solid and Liquid Biopsy for Therapy Monitoring in Esophageal Cancer. Richter F; Henssen C; Steiert TA; Meissner T; Mehdorn AS; Röcken C; Franke A; Egberts JH; Becker T; Sebens S; Forster M Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445849 [TBL] [Abstract][Full Text] [Related]
3. Liquid Biopsy for Investigation of Cancer DNA in Esophageal Squamous Cell Carcinoma. Smith RA; Lam AK Methods Mol Biol; 2020; 2129():203-215. PubMed ID: 32056180 [TBL] [Abstract][Full Text] [Related]
4. Genome-wide and size-based cell-free DNA indices as predictive biomarkers for locally advanced esophageal squamous cell carcinoma treated with preoperative or definitive chemoradiotherapy. Kim EJ; Im HS; Lee J; Cho EH; Kim YH; Kim HR; Kim JH; Park SR Curr Probl Cancer; 2021 Jun; 45(3):100685. PubMed ID: 33342577 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review. Cervena K; Vodicka P; Vymetalkova V Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571 [TBL] [Abstract][Full Text] [Related]
6. Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study. Bian Y; Gao Y; Lin H; Sun C; Wang W; Sun S; Li X; Feng Z; Ren J; Chen H; Lu C; Xu J; Zhou J; Wan K; Xin L; Li Z; Wang L J Hematol Oncol; 2024 Jun; 17(1):47. PubMed ID: 38890756 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and monitoring of virus-associated cancer using cell-free DNA. Scholte LL; Bethony JM; Xian RR Curr Opin Virol; 2023 Jun; 60():101331. PubMed ID: 37187125 [TBL] [Abstract][Full Text] [Related]
8. Impact of Tissue Enolase 1 Protein Overexpression in Esophageal Cancer Progression. Hoang AT; Vizio B; Chiusa L; Cimino A; Solerio D; Do NH; Pileci S; Camandona M; Bellone G Int J Med Sci; 2021; 18(6):1406-1414. PubMed ID: 33628097 [TBL] [Abstract][Full Text] [Related]
9. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence. Ueda M; Iguchi T; Masuda T; Nakahara Y; Hirata H; Uchi R; Niida A; Momose K; Sakimura S; Chiba K; Eguchi H; Ito S; Sugimachi K; Yamasaki M; Suzuki Y; Miyano S; Doki Y; Mori M; Mimori K Oncotarget; 2016 Sep; 7(38):62280-62291. PubMed ID: 27556701 [TBL] [Abstract][Full Text] [Related]
10. Leveraging cfDNA fragmentomic features in a stacked ensemble model for early detection of esophageal squamous cell carcinoma. Jiao Z; Zhang X; Xuan Y; Shi X; Zhang Z; Yu A; Li N; Yang S; He X; Zhao G; Yang R; Chen J; Wu X; Bao H; Wang F; Ren W; Liang H; Chen Q; Wang T Cell Rep Med; 2024 Aug; 5(8):101664. PubMed ID: 39089259 [TBL] [Abstract][Full Text] [Related]
11. Plasma cell-free DNA 5-hydroxymethylcytosine and whole-genome sequencing signatures for early detection of esophageal cancer. Lu D; Wu X; Wu W; Wu S; Li H; Zhang Y; Yan X; Zhai J; Dong X; Feng S; Zhang X; Sun F; Wang S; Cai K Cell Death Dis; 2023 Dec; 14(12):843. PubMed ID: 38114477 [TBL] [Abstract][Full Text] [Related]
12. Advances in biomarker discovery using circulating cell-free DNA for early detection of hepatocellular carcinoma. Liu M; Zhang Z; Zhang W; Liu SM WIREs Mech Dis; 2023; 15(3):e1598. PubMed ID: 36697374 [TBL] [Abstract][Full Text] [Related]
13. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies. Jiang P; Chan KCA; Lo YMD J Hepatol; 2019 Aug; 71(2):409-421. PubMed ID: 31004682 [TBL] [Abstract][Full Text] [Related]
14. Discovery and validation of methylation signatures in circulating cell-free DNA for early detection of esophageal cancer: a case-control study. Qiao G; Zhuang W; Dong B; Li C; Xu J; Wang G; Xie L; Zhou Z; Tian D; Chen G; Tang J; Zhou H; Zhang D; Shi R; Chen R; Nian W; Zhang Y; Zhao J; Wen X; Xu Y; Li B; Zhang Z; Cai S; Ben X; Qi Y BMC Med; 2021 Oct; 19(1):243. PubMed ID: 34641873 [TBL] [Abstract][Full Text] [Related]
15. Circulating DNA in Esophageal Cancer-Utility Beyond the Prognostic Application. Tankel J; Ferri LE JAMA Surg; 2023 Nov; 158(11):1150-1151. PubMed ID: 37728891 [No Abstract] [Full Text] [Related]
16. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer. Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642 [TBL] [Abstract][Full Text] [Related]
17. Circulating Cell-Free DNA Levels Could Predict Oncological Outcomes of Patients Undergoing Esophagectomy for Esophageal Squamous Cell Carcinoma. Hsieh CC; Hsu HS; Chang SC; Chen YJ Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999323 [TBL] [Abstract][Full Text] [Related]
18. From blood to breath: New horizons for esophageal cancer biomarkers. Yazbeck R; Jaenisch SE; Watson DI World J Gastroenterol; 2016 Dec; 22(46):10077-10083. PubMed ID: 28028355 [TBL] [Abstract][Full Text] [Related]
19. Circulating cell-free DNA-based methylation pattern in plasma for early diagnosis of esophagus cancer. Wang R; Yang Y; Lu T; Cui Y; Li B; Liu X PeerJ; 2024; 12():e16802. PubMed ID: 38313016 [TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer. Chen H; Xu C; Fang Z; Mao S Methods Mol Biol; 2023; 2695():165-179. PubMed ID: 37450118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]